242 related articles for article (PubMed ID: 27846736)
21. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
Grunst MW; Ladd RA; Clark NM; Gil HM; Klenchin VA; Mason R; Franchini G; Roederer M; Evans DT
PLoS Pathog; 2023 May; 19(5):e1011407. PubMed ID: 37253062
[TBL] [Abstract][Full Text] [Related]
23. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
[TBL] [Abstract][Full Text] [Related]
24. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.
Smalls-Mantey A; Doria-Rose N; Klein R; Patamawenu A; Migueles SA; Ko SY; Hallahan CW; Wong H; Liu B; You L; Scheid J; Kappes JC; Ochsenbauer C; Nabel GJ; Mascola JR; Connors M
J Virol; 2012 Aug; 86(16):8672-80. PubMed ID: 22674985
[TBL] [Abstract][Full Text] [Related]
25. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
[TBL] [Abstract][Full Text] [Related]
26. Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.
Richard J; Prévost J; Baxter AE; von Bredow B; Ding S; Medjahed H; Delgado GG; Brassard N; Stürzel CM; Kirchhoff F; Hahn BH; Parsons MS; Kaufmann DE; Evans DT; Finzi A
mBio; 2018 Mar; 9(2):. PubMed ID: 29559570
[TBL] [Abstract][Full Text] [Related]
27. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
[TBL] [Abstract][Full Text] [Related]
28. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
Front Immunol; 2020; 11():583820. PubMed ID: 33101312
[TBL] [Abstract][Full Text] [Related]
29. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
[TBL] [Abstract][Full Text] [Related]
30. Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.
Veillette M; Richard J; Pazgier M; Lewis GK; Parsons MS; Finzi A
Curr HIV Res; 2016; 14(1):9-23. PubMed ID: 26310828
[TBL] [Abstract][Full Text] [Related]
31. eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
Davis-Gardner ME; Gardner MR; Alfant B; Farzan M
PLoS Pathog; 2017 Dec; 13(12):e1006786. PubMed ID: 29253851
[TBL] [Abstract][Full Text] [Related]
32. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
Matsumoto K; Kuwata T; Tolbert WD; Richard J; Ding S; Prévost J; Takahama S; Judicate GP; Ueno T; Nakata H; Kobayakawa T; Tsuji K; Tamamura H; Smith AB; Pazgier M; Finzi A; Matsushita S
J Virol; 2023 Jan; 97(1):e0163822. PubMed ID: 36511698
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.
Tokarev A; Stoneham C; Lewinski MK; Mukim A; Deshmukh S; Vollbrecht T; Spina CA; Guatelli J
J Virol; 2015 Dec; 90(5):2486-502. PubMed ID: 26676780
[TBL] [Abstract][Full Text] [Related]
35. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.
Anand SP; Prévost J; Baril S; Richard J; Medjahed H; Chapleau JP; Tolbert WD; Kirk S; Smith AB; Wines BD; Kent SJ; Hogarth PM; Parsons MS; Pazgier M; Finzi A
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429344
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.
Prévost J; Medjahed H; Vézina D; Chen HC; Hahn BH; Smith AB; Finzi A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835042
[TBL] [Abstract][Full Text] [Related]
37. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
Mielke D; Stanfield-Oakley S; Borate B; Fisher LH; Faircloth K; Tuyishime M; Greene K; Gao H; Williamson C; Morris L; Ochsenbauer C; Tomaras G; Haynes BF; Montefiori D; Pollara J; deCamp AC; Ferrari G
J Virol; 2022 Jan; 96(2):e0164321. PubMed ID: 34730393
[TBL] [Abstract][Full Text] [Related]
38. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity.
Marchitto L; Richard J; Prévost J; Tauzin A; Yang D; Chiu T; Chen HC; Díaz-Salinas MA; Nayrac M; Benlarbi M; Beaudoin-Bussières G; Anand SP; Dionne K; Bélanger É; Chatterjee D; Medjahed H; Bourassa C; Tolbert WD; Hahn BH; Munro JB; Pazgier M; Smith AB; Finzi A
bioRxiv; 2024 Jun; ():. PubMed ID: 38895270
[TBL] [Abstract][Full Text] [Related]
39. Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.
Guan Y; Pazgier M; Sajadi MM; Kamin-Lewis R; Al-Darmarki S; Flinko R; Lovo E; Wu X; Robinson JE; Seaman MS; Fouts TR; Gallo RC; DeVico AL; Lewis GK
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E69-78. PubMed ID: 23237851
[TBL] [Abstract][Full Text] [Related]
40. Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity.
Laumaea A; Marchitto L; Ding S; Beaudoin-Bussières G; Prévost J; Gasser R; Chatterjee D; Gendron-Lepage G; Medjahed H; Chen HC; Smith AB; Ding H; Kappes JC; Hahn BH; Kirchhoff F; Richard J; Duerr R; Finzi A
Cell Rep; 2023 Jan; 42(1):111983. PubMed ID: 36640355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
